These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 30673295)
101. MR-Guided Radiotherapy for Liver Malignancies. Boldrini L; Corradini S; Gani C; Henke L; Hosni A; Romano A; Dawson L Front Oncol; 2021; 11():616027. PubMed ID: 33869001 [TBL] [Abstract][Full Text] [Related]
102. The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer. Gkika E; Hawkins MA; Grosu AL; Brunner TB Front Oncol; 2020; 10():604387. PubMed ID: 33381458 [TBL] [Abstract][Full Text] [Related]
103. Modern therapeutic approaches for the treatment of malignant liver tumours. Petrowsky H; Fritsch R; Guckenberger M; De Oliveira ML; Dutkowski P; Clavien PA Nat Rev Gastroenterol Hepatol; 2020 Dec; 17(12):755-772. PubMed ID: 32681074 [TBL] [Abstract][Full Text] [Related]
104. Actual over 3-year survival after stereotactic body radiation therapy in patients with unresectable intrahepatic cholangiocarcinoma. Zhang XX; Ma HB; Li TH; Huang B; Jia NY; Meng Y Clin Transl Oncol; 2023 Mar; 25(3):731-738. PubMed ID: 36401766 [TBL] [Abstract][Full Text] [Related]
105. Improving patient selection for selective internal radiation therapy of intra-hepatic cholangiocarcinoma: A meta-regression study. Cucchetti A; Cappelli A; Mosconi C; Zhong JH; Cescon M; Pinna AD; Golfieri R Liver Int; 2017 Jul; 37(7):1056-1064. PubMed ID: 28177190 [TBL] [Abstract][Full Text] [Related]
106. Stereotactic body radiation therapy in cholangiocarcinoma: a systematic review. Frakulli R; Buwenge M; Macchia G; Cammelli S; Deodato F; Cilla S; Cellini F; Mattiucci GC; Bisello S; Brandi G; Parisi S; Morganti AG Br J Radiol; 2019 May; 92(1097):20180688. PubMed ID: 30673295 [TBL] [Abstract][Full Text] [Related]
107. Efficacy of stereotactic body radiotherapy for unresectable or recurrent cholangiocarcinoma: a meta-analysis and systematic review. Lee J; Yoon WS; Koom WS; Rim CH Strahlenther Onkol; 2019 Feb; 195(2):93-102. PubMed ID: 30206644 [TBL] [Abstract][Full Text] [Related]
109. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity. Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292 [TBL] [Abstract][Full Text] [Related]
110. Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. Brunner TB; Blanck O; Lewitzki V; Abbasi-Senger N; Momm F; Riesterer O; Duma MN; Wachter S; Baus W; Gerum S; Guckenberger M; Gkika E Radiother Oncol; 2019 Mar; 132():42-47. PubMed ID: 30825968 [TBL] [Abstract][Full Text] [Related]
111. Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience. Polistina FA; Guglielmi R; Baiocchi C; Francescon P; Scalchi P; Febbraro A; Costantin G; Ambrosino G Radiother Oncol; 2011 May; 99(2):120-3. PubMed ID: 21621289 [TBL] [Abstract][Full Text] [Related]
112. Clinical outcomes and prognostic factors of stereotactic body radiation therapy for intrahepatic cholangiocarcinoma. Shen ZT; Zhou H; Li AM; Li B; Shen JS; Zhu XX Oncotarget; 2017 Nov; 8(55):93541-93550. PubMed ID: 29212171 [TBL] [Abstract][Full Text] [Related]
113. Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma. Sandler KA; Veruttipong D; Agopian VG; Finn RS; Hong JC; Kaldas FM; Sadeghi S; Busuttil RW; Lee P Adv Radiat Oncol; 2016; 1(4):237-243. PubMed ID: 28740893 [TBL] [Abstract][Full Text] [Related]